Laserfiche WebLink
Page 2 of 5 <br />Table 1. Projected Future Opioid Allocations (2025-2038): <br />Payment Type Distribution Years Projected Allocation <br />Distributor 2025-2038 $598,111 <br />Janssen 2025-2031 $90,081 <br />Teva 2025-2035 $134,242 <br />Allergan 2025-2029 $67,003 <br />CVS 2025-2032 $190,130 <br />Walgreens 2026-2037 $209,995 <br />Walmart 2025-2028 $7,525 <br />Total $1,297,089 <br /> <br />Allowable Uses of Opioid Settlement Funds <br />In addition to the direct opioid remediation activities outlined within the settlement agreements, <br />California has designated a set of five High Impact Abatement Activities (HIAA): <br />1. Provision of matching funds or operating costs for substance use disorder facilities with <br />an approved project within the Behavioral Health Continuum Infrastructure Program <br />(BHCIP) <br />2. Creating new or expanded substance use disorder (SUD) treatment infrastructure <br />3. Addressing the needs of communities of color and vulnerable populations (including <br />sheltered and unsheltered homeless populations) that are disproportionately impacted <br />by SUD <br />4. Diversion of people with SUD from the justice system into treatment, including by <br />providing training and resources to first and early responders (sworn and non-sworn) <br />and implementing best practices for outreach, diversion and deflection, employability, <br />restorative justice, and harm reduction <br />5. Interventions to prevent drug addiction in vulnerable youth <br /> <br />Past Uses of Opioid Settlement Funds <br /> <br />Funds were previously used to support access to primary care services for the unhoused <br />community within the city of Pleasanton through Axis Community Health, particularly for those <br />individuals disproportionately impacted by substance use disorders. Funds allowed for the <br />weekly use of 1-on-1 primary care provider slots. During the primary care visit, the unhoused <br />individual received the following services as necessary: screening of the patient’s social <br />determinants of health (SDOH), care coordination consultations and resources, primary care <br />visit with an MD, warm handoffs to our integrated behavioral health team. Approximately 80% <br />of the patients presenting for services have a history of significant substance-use disorders or <br />Page 18 of 264